NUS INVENTS NEW WAY TO PRODUCE COVID-19 SWAB

July 14, 2020

NUS invents new way to produce Covid-19 swab, 40 million to be produced in coming months

 

Read the full article and more about our portfolio Meiban Group here

Source: Straits Times ©. Permission required for reproduction.

We are an award winning South East Asia Focused private equity firm, investing in lower mid-market space. Owned and managed by Southeast Asian professionals with multi-year track record of successful investments. We are the private equity arm of Dymon Asia Capital

© 2022 Dymon Asia Private Equity